Norsk forening for medisinsk mikrobiologi


Publikasjoner i 2011

    1.   Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, et al. Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity. Clin Vaccine Immunol 2011 Aug;18:1269-74.

      2.   Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, et al. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci). J Clin Microbiol 2011 Apr;49:1475-82.

      3.   Anestad G, Nordbo SA. Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway? Med Hypotheses 2011 Dec;77:1132-4.

      4.   Asberg A, Jardine AG, Bignamini AA, Rollag H, Gahlemann CC, Humar A, et al. Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV disease. Am J Transplant 2011 May;11:1103-4.

      5.   Bech-Nielsen GV, Hansen CH, Hufeldt MR, Nielsen DS, Aasted B, Vogensen FK, et al. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Res Vet Sci 2011 May 2.

      6.   Benam AV, Lang E, Alfsnes K, Fleckenstein B, Rowe AD, Hovland E, et al. Structure-function relationships of the competence lipoprotein ComL and SSB in meningococcal transformation. Microbiology 2011 May;157:1329-42.

      7.   Bengtsson S, Naseer U, Sundsfjord A, Kahlmeter G, Sundqvist M. Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. J Antimicrob Chemother 2012 Jan;67:69-73.

      8.   Benno P, Dahlgren AL, Midtvedt T. [Helicobacter pylori--a friend in need]. Lakartidningen 2011 Nov 2;108:2232.

      9.   Benno P, Bark J, Collinder E, Hellstrom PM, Midtvedt T, Norin E. Major alterations in metabolic activity of intestinal microflora in Crohn's disease. Scand J Gastroenterol 2012 Feb;47:251-2.

     10.   Bjerkan G, Witso E, Nor A, Viset T, Loseth K, Lydersen S, et al. A comprehensive microbiological evaluation in fifty-four patients undergoing revision surgery due to prosthetic joint loosening. J Med Microbiol 2011 Dec 1.

     11.   Bjerke SE, Vangen S, Holter E, Stray-Pedersen B. Infectious immune status in an obstetric population of Pakistani immigrants in Norway. Scand J Public Health 2011 Jul;39:464-70.

     12.   Bjorkeng E, Rasmussen G, Sundsfjord A, Sjoberg L, Hegstad K, Soderquist B. Clustering of polyclonal VanB-type vancomycin-resistant Enterococcus faecium in a low-endemic area was associated with CC17-genogroup strains harbouring transferable vanB2-Tn5382 and pRUM-like repA containing plasmids with axe-txe plasmid addiction systems. APMIS 2011 Apr;119:247-58.

     13.   Borra PS, Leiros HK, Ahmad R, Spencer J, Leiros I, Walsh TR, et al. Structural and computational investigations of VIM-7: insights into the substrate specificity of vim metallo-beta-lactamases. J Mol Biol 2011 Aug 5;411:174-89.

     14.   Cruz ED, Pimenta FC, Andersen BM, Gir E. Lessons to learn with the methicillin-resistant Staphylococcus aureus control in Norway. Braz J Infect Dis 2011 Dec;15:591-3.

     15.   du PK, Mandalakas AM, Kirchner HL, Grewal HM, Schaaf HS, van Wyk SS, et al. Environmental tobacco smoke exposure increases Mycobacterium tuberculosis infection risk in children. Int J Tuberc Lung Dis 2011 Nov;15:1490-6, i.

     16.   Duri K, Gumbo FZ, Kristiansen KI, Mapingure MP, Munjoma MW, Chirenje MZ, et al. Phylogenetic Analysis of Human Immunodeficiency Virus type 1 (HIV-1) Subtype C Env gp 120 sequences among four drug naive families following subsequent heterosexual and vertical transmissions. AIDS Res Hum Retroviruses 2011 Dec 29.

     17.   Duri K, Muller F, Gumbo FZ, Kurewa NE, Rusakaniko S, Chirenje MZ, et al. Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naive pregnant women in Harare, Zimbabwe. BMC Infect Dis 2011;11:7.

     18.   Eggesbo M, Moen B, Peddada S, Baird D, Rugtveit J, Midtvedt T, et al. Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011 Jan;119:17-35.

     19.   Fagernes M, Lingaas E. Factors interfering with the microflora on hands: a regression analysis of samples from 465 healthcare workers. J Adv Nurs 2011 Feb;67:297-307.

     20.   Gammelsrud KW, Sandven P, Hoiby EA, Sandvik L, Brandtzaeg P, Gaustad P. Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls. Clin Microbiol Infect 2011 Dec;17:1875-81.

     21.   Gebremariam MK, Bjune GA, Frich JC. Lay beliefs of TB and TB/HIV co-infection in Addis Ababa, Ethiopia: a qualitative study. BMC Res Notes 2011;4:277.

     22.   Ghaderi S, Nordbo SA, Bakken IJ. [Chlamydia infections in South Trondelag--treatment and follow-up]. Tidsskr Nor Laegeforen 2011 Mar 4;131:461-3.

     23.   Giske CG, Gezelius L, Samuelsen O, Warner M, Sundsfjord A, Woodford N. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011 Apr;17:552-6.

     24.   Gonzalez CA, Megraud F, Buissonniere A, Lujan BL, Agudo A, Duell EJ, et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol 2011 Oct 21.

     25.   Grimnes G, Beckman H, Lappegard KT, Mollnes TE, Skogen V. Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report. APMIS 2011 Jul;119:479-84.

     26.   Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Forre O, Almdahl SM, et al. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions. Rheumatology (Oxford) 2011 Dec 11.

     27.   Guzman-Herrador B, Vold L, Comelli H, MacDonald E, Heier BT, Wester AL, et al. Outbreak of Shigella sonnei infection in Norway linked to consumption of fresh basil, October 2011. Euro Surveill 2011;16.

     28.   Hartgill U, Jakopanec I, Vestrheim DF. [Gonorrhea--time for new guidelines]. Tidsskr Nor Laegeforen 2011 Apr 8;131:671-2.

     29.   Hasle G, Bjune GA, Midthjell L, Roed KH, Leinaas HP. Transport of Ixodes ricinus infected with Borrelia species to Norway by northward-migrating passerine birds. Ticks Tick Borne Dis 2011 Mar;2:37-43.

     30.   Haug JB, Berild D, Walberg M, Reikvam A. Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate. J Antimicrob Chemother 2011 Nov;66:2643-6.

     31.   Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM. Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses. J Travel Med 2011 Nov;18:418-21.

     32.   Hjelmevoll SO, Golparian D, Dedi L, Skutlaberg DH, Haarr E, Christensen A, et al. Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines. Eur J Clin Microbiol Infect Dis 2011 Sep 30.

     33.   Holberg-Petersen M, Jenum PA, Mannsaker T, Melby KK. Comparison of PCR with culture applied on nasopharyngeal and throat swab specimens for the detection of Bordetella pertussis. Scand J Infect Dis 2011 Mar;43:221-4.

     34.   Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 2011 Dec 16.

     35.   Johansen JS, Westergren T, Lingaas E. [Post-exposure varicella prophylaxis]. Tidsskr Nor Laegeforen 2011 Sep 6;131:1645-8.

     36.   Johnsen BO, Ronning EJ, Onken A, Figved W, Jenum PA. Dolosigranulum pigrum causing biomaterial-associated arthritis. APMIS 2011 Feb;119:85-7.

     37.   Johnsen PJ, Townsend JP, Bohn T, Simonsen GS, Sundsfjord A, Nielsen KM. Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures. J Antimicrob Chemother 2011 Mar;66:608-10.

     38.   Kaarbo M, Ager-Wick E, Osenbroch PO, Kilander A, Skinnes R, Muller F, et al. Human cytomegalovirus infection increases mitochondrial biogenesis. Mitochondrion 2011 Nov;11:935-45.

     39.   Karah N, Haldorsen B, Hermansen NO, Tveten Y, Ragnhildstveit E, Skutlaberg DH, et al. Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J Med Microbiol 2011 Apr;60:515-21.

     40.   Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen O. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 2011 Apr;66:738-44.

     41.   Karah N, Giske CG, Sundsfjord A, Samuelsen O. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages. Microb Drug Resist 2011 Dec;17:545-9.

     42.   Kittang BR, Skrede S, Langeland N, Haanshuus CG, Mylvaganam H. emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway. Eur J Clin Microbiol Infect Dis 2011 Mar;30:423-33.

     43.   Kittang BR, Bruun T, Langeland N, Mylvaganam H, Glambek M, Skrede S. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin Microbiol Infect 2011 Mar;17:358-64.

     44.   Kommedal O, Lekang K, Langeland N, Wiker HG. Characterization of polybacterial clinical samples using a set of group-specific broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis. J Med Microbiol 2011 Jul;60:927-36.

     45.   Kristiansen MG, Lochen ML, Gutteberg TJ, Mortensen L, Eriksen BO, Florholmen J. Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway. J Viral Hepat 2011 Apr;18:237-44.

     46.   Kristoffersen AW, Nordbo SA, Rognlien AG, Christensen A, Dollner H. Coronavirus causes lower respiratory tract infections less frequently than RSV in hospitalized Norwegian children. Pediatr Infect Dis J 2011 Apr;30:279-83.

     47.   Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, et al. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med 2011;19:44.

     48.   Kuch A, Willems RJ, Werner G, Coque TM, Hammerum AM, Sundsfjord A, et al. Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother 2011 Dec 29.

     49.   Kvam AI, Mavenyengwa RT, Radtke A, Maeland JA. Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes. Clin Vaccine Immunol 2011 Aug;18:1365-70.

     50.   Larssen KW, Afset JE, Heier BT, Krogh T, Handeland K, Vikoren T, et al. Outbreak of tularaemia in central Norway, January to March 2011. Euro Surveill 2011;16.

     51.   Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, Macgowan AP, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2011 Oct 21.

     52.   Lier T. [Fish and flatworms in Vietnam]. Tidsskr Nor Laegeforen 2011 Sep 20;131:1799-801.

     53.   Lillenes MS, Espeseth T, Stoen M, Lundervold AJ, Frye SA, Rootwelt H, et al. DNA base excision repair gene polymorphisms modulate human cognitive performance and decline during normal life span. Mech Ageing Dev 2011 Aug;132:449-58.

     54.   Linde M, Langnes HA, Hagen K, Bergh K, Stovner LJ. No increase in headache after previous intracranial infections: a historical cohort study (HUNT). Eur J Neurol 2012 Feb;19:324-31.

     55.   Lisboa LF, Tong Y, Kumar D, Pang XL, Asberg A, Hartmann A, et al. Analysis and clinical correlation of genetic variation in cytomegalovirus. Transpl Infect Dis 2011 Oct 14.

     56.   Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011 Jan 27;91:231-6.

     57.   Moi H, Vestrheim DF, Olsen AO. [Reduce the use of one-dose azithromycin]. Tidsskr Nor Laegeforen 2011 Apr 8;131:673-4.

     58.   Mouton JW, Brown DF, Apfalter P, Canton R, Giske CG, Ivanova M, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect 2011 Dec 8.

     59.   Moyo SJ, Gro N, Matee MI, Kitundu J, Myrmel H, Mylvaganam H, et al. Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in Dar es Salaam, Tanzania. BMC Pediatr 2011;11:19.

     60.   Myhre HA, Haug DD, Kristiansen KI, Rollag H, Leivestad T, Asberg A, et al. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 2011 Jul 27;92:217-23.

     61.   Naaber P, Stsepetova J, Smidt I, Ratsep M, Koljalg S, Loivukene K, et al. Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients. J Clin Microbiol 2011 Oct;49:3656-8.

     62.   Naalsund A, Lund MB, Mynarek G, Aakhus S, Boberg KM, Nordoy I. [A man in his 60s with severe respiratory failure]. Tidsskr Nor Laegeforen 2011 Sep 6;131:1654-7.

     63.   Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 2011 Mar;17:83-97.

     64.   Nilsen E, Vik E, Roed MA. Low prevalence of Mycoplasma genitalium in patients examined for Chlamydia trachomatis. Tidsskr Nor Laegeforen 2011 Nov 15;131:2232-4.

     65.   Nilsson LE, Frimodt-Moller N, Vaara M, Simonsen GS. Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countries. Scand J Infect Dis 2011 Sep;43:707-13.

     66.   Nordbo SA. [Hvilke prøver er best til påvisning av Chlamydia trachomatis?]. Tidsskr Nor Laegeforen 2011 Nov 29;131:2333.

     67.   Olsen K, Falch BM, Danielsen K, Johannessen M, Ericson Sollid JU, Thune I, et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromso Staph and Skin Study. Eur J Clin Microbiol Infect Dis 2011 Aug 3.

     68.   Os I, Gudmundsdottir H, Draganov B, von der LE. Sterile peritonitis associated with amino acid-containing dialysate--a single center experience in Norway. Perit Dial Int 2011 Jan;31:103.

     69.   Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, et al. An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses. J Virol 2011 Jul;85:6557-66.

     70.   Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J Nutr 2011 Apr 1;141:685-91.

     71.   Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Trans R Soc Trop Med Hyg 2011 Mar;105:140-7.

     72.   Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. Br J Nutr 2012 Jan;107:263-71.

     73.   Rasmussen I, Wallace S, Mengshoel AT, Hoiby EA, Brandtzaeg P. Diphtheria outbreak in Norway: lessons learned. Scand J Infect Dis 2011 Dec;43:986-9.

     74.   Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P, et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 2011;6:e17996.

     75.   Rodland EK, Ager-Wick E, Halvorsen B, Muller F, Froland SS. Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro. Med Mycol 2011 May;49:375-9.

     76.   Rortveit S, Skutlaberg DH, Langeland N, Rortveit G. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. J Antimicrob Chemother 2011 Jun;66:1360-4.

     77.   Sagbakken M, Bjune GA, Frich JC. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway. Scand J Caring Sci 2011 Nov 2.

     78.   Samuelsen O, Toleman MA, Hasseltvedt V, Fuursted K, Leegaard TM, Walsh TR, et al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect 2011 Dec;17:1811-6.

     79.   Samuelsen O, Thilesen CM, Heggelund L, Vada AN, Kummel A, Sundsfjord A. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother 2011 Mar;66:670-2.

     80.   Sangvik M, Olsen RS, Olsen K, Simonsen GS, Furberg AS, Sollid JU. Age- and gender-associated Staphylococcus aureus spa types found among nasal carriers in a general population: the Tromso Staph and Skin Study. J Clin Microbiol 2011 Dec;49:4213-8.

     81.   Sepp E, Stsepetova J, Smidt I, Ratsep M, Koljalg S, Loivukene K, et al. Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe 2011 Dec;17:407-9.

     82.   Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res 2011 Oct;92:115-23.

     83.   Simonsen KA, Hunskaar S, Wensaas KA, Rortveit S, Cox R, Njolstad G, et al. Influenza-like illness in general practice in Norway: clinical course and attitudes towards vaccination and preventive measures during the 2009 pandemic. Fam Pract 2011 Sep 5.

     84.   Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011 Dec;17:1859-67.

     85.   Skram MK, Bjering S, Hermansen NO, Dini L, Hellebostad M. A 15-month-old girl with fever and pancytopenia. Tidsskr Nor Laegeforen 2011 Dec 13;131:2482-6.

     86.   Skramm I, Moen AE, Bukholm G. Nasal carriage of Staphylococcus aureus: frequency and molecular diversity in a randomly sampled Norwegian community population. APMIS 2011 Aug;119:522-8.

     87.   Sorbye S, Fismen S, Gutteberg TJ, Mortensen E. [HPV testing and cervix cancer]. Tidsskr Nor Laegeforen 2011 Feb 18;131:333.

     88.   Sorbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES. HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy. PLoS One 2011;6:e26022.

     89.   Sorbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES. Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology. PLoS One 2011;6:e24083.

     90.   Stavrum R, Stavrum AK, Valvatne H, Riley LW, Ulvestad E, Jonassen I, et al. Modulation of transcriptional and inflammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLoS One 2011;6:e26295.

     91.   Sun J, Sundsfjord A, Song X. Enterococcus faecalis from patients with chronic periodontitis: virulence and antimicrobial resistance traits and determinants. Eur J Clin Microbiol Infect Dis 2011 Jun 10.

     92.   Sunde M, Tharaldsen H, Marstein L, Haugum M, Norstrom M, Jacobsen T, et al. Detection of methicillin-resistant Staphylococcus aureus sequence type 8 in pigs, production environment, and human beings. J Vet Diagn Invest 2011 Mar;23:348-50.

     93.   Thorstad M, Sie I, Andersen BM. MRSA: A Challenge to Norwegian Nursing Home Personnel. Interdiscip Perspect Infect Dis 2011;2011:197683.

     94.   Tomazella GG, Risberg K, Mylvaganam H, Lindemann PC, Thiede B, de Souza GA, et al. Proteomic analysis of a multi-resistant clinical Escherichia coli isolate of unknown genomic background. J Proteomics 2011 Dec 30.

     95.   Tonjum T, Koomey M. Kiss and run - phosphoglycerol modifications of N. Meningitidis pili mediate detachment. Front Microbiol 2011;2:82.

     96.   Tveten Y, Sarjomaa MA, Skaare D, Grude N, Samuelsen O. [How to stop multiresistant bacteria?]. Tidsskr Nor Laegeforen 2011 Apr 8;131:698-700.

     97.   Vading M, Samuelsen O, Haldorsen B, Sundsfjord AS, Giske CG. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems. Clin Microbiol Infect 2011 May;17:668-74.

     98.   Vainio K, Ronning K, Steen TW, Arnesen TM, Anestad G, Dudman S. Ongoing outbreak of measles in Oslo, Norway, January-February 2011. Euro Surveill 2011;16.

     99.   Valeur J, Berstad A, Midtvedt T. [Intestinal auto-intoxication--still a current disease mechanism?]. Tidsskr Nor Laegeforen 2011 Oct 4;131:1875-6.

   100.   Vestrheim DF, Gaustad P, Aaberge IS, Caugant DA. Pherotypes of pneumococcal strains co-existing in healthy children. Infect Genet Evol 2011 Oct;11:1703-8.

   101.   Vestrheim DF, Gaustad P, Aaberge IS, Caugant DA. Pherotypes of pneumococcal strains co-existing in healthy children. Infect Genet Evol 2011 Oct;11:1703-8.

   102.   Vik IS, Dudman SG, Hungnes O, Hoddevik G. [Wrongly informed about influenza serology]. Tidsskr Nor Laegeforen 2011 Jan 21;131:110-1.

   103.   Visser ME, Grewal HM, Swart EC, Dhansay MA, Walzl G, Swanevelder S, et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. Am J Clin Nutr 2011 Jan;93:93-100.

   104.   Waagsbo B, Tofteland S, Kittang OB. [Young girl with abscesses in the face]. Tidsskr Nor Laegeforen 2011 Nov 15;131:2246-8.

   105.   Wahl E, Vold L, Lindstedt BA, Bruheim T, Afset JE. Investigation of an Escherichia coli O145 outbreak in a child day-care centre--extensive sampling and characterization of eae- and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infect Dis 2011;11:238.

   106.   Walberg M. Our data are good enough. Tidsskr Nor Laegeforen 2011 Aug 9;131:1414.

   107.   Walberg M. Improvement requires good data. Tidsskr Nor Laegeforen 2011 Apr 8;131:670-1.

   108.   Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, et al. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol 2011 Dec;85:13195-203.

   109.   Werner G, Freitas AR, Coque TM, Sollid JE, Lester C, Hammerum AM, et al. Host range of enterococcal vanA plasmids among Gram-positive intestinal bacteria. J Antimicrob Chemother 2011 Feb;66:273-82.

   110.   Yang M, Aamodt RM, Dalhus B, Balasingham S, Helle I, Andersen P, et al. The ada operon of Mycobacterium tuberculosis encodes two DNA methyltransferases for inducible repair of DNA alkylation damage. DNA Repair (Amst) 2011 Jun 10;10:595-602.

   111.   Yimer SA, Hansen CH, Bjune GA. The perspective of private practitioners regarding tuberculosis case detection and treatment delay in Amhara Region, Ethiopia: a cross-sectional study. BMC Res Notes 2011;4:285.

   112.   Yri OE, Torfoss D, Hungnes O, Tierens A, Waalen K, Nordoy T, et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 2011 Dec 22;118:6769-71.

   113.   Zinocker S, Wang MY, Gaustad P, Kvalheim G, Rolstad B, Vaage JT. Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro. PLoS One 2011;6:e16005.